Overview
- 7 inspections across 6 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-06-28.
At a glance
Inspections
7
Sites
6
Observations
0
Career since
Feb 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Grifols Diagnostic Solutions, INC. | 28 Jun 2024 | Biologics | On file |
| Grifols Therapeutics LLC | 1 Sep 2023 | Biologics | On file |
| FinVector Oy | 28 Jan 2020 | Biologics | On file |
| Jubilant HollisterStier LLC | 14 Jun 2019 | Biologics | On file |
| Kedrion Biopharma Inc. | 16 Nov 2018 | Biologics | On file |
Sites inspected
Grifols Diagnostic Solutions, INC.San Diego, United States1 insp.
Grifols Therapeutics LLCClayton, United States1 insp.
FinVector OyKuopio, Finland1 insp.
Jubilant HollisterStier LLCSpokane, United States1 insp.
Kedrion Biopharma Inc.Melville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Emilia A Sippert1 shared
Antonia L Panthiruvelil1 shared
Zhugong Liu1 shared
Kula N Jha1 shared
Yonggang Wang1 shared
Zhili Xu1 shared
Ramjay S Vatsan1 shared
Anurag Sharma1 shared
Susan M Jackson1 shared
Laura Fontan1 shared
Full investigator report
Get the verbatim findings behind Bradley J Dworak's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site